Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
Full story
Read the full story at The Economic Times (India) ↗
Continue reading this story on The Economic Times (India), the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
